To the best of our knowledge, the expression of PD-L1 and PD-1 and the abundance of a comprehensive panel of tumour-infiltrating immune cells in BRCA1- and BRCA2-deficient breast cancers have hitherto not been described. The gene discussed is BRCA2; the disease is neoplasm.